JPWO2023286027A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023286027A5 JPWO2023286027A5 JP2024502018A JP2024502018A JPWO2023286027A5 JP WO2023286027 A5 JPWO2023286027 A5 JP WO2023286027A5 JP 2024502018 A JP2024502018 A JP 2024502018A JP 2024502018 A JP2024502018 A JP 2024502018A JP WO2023286027 A5 JPWO2023286027 A5 JP WO2023286027A5
- Authority
- JP
- Japan
- Prior art keywords
- strain
- group
- dsm
- lactobacillus paracasei
- ibs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000018740 | 2021-07-15 | ||
| IT102021000018740A IT202100018740A1 (it) | 2021-07-15 | 2021-07-15 | Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati |
| PCT/IB2022/056538 WO2023286027A1 (en) | 2021-07-15 | 2022-07-15 | Use of lactobacillus paracasei bacterial strains in the treatment of newborns |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525794A JP2024525794A (ja) | 2024-07-12 |
| JP2024525794A5 JP2024525794A5 (https=) | 2025-07-08 |
| JPWO2023286027A5 true JPWO2023286027A5 (https=) | 2025-07-08 |
Family
ID=78212428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502018A Pending JP2024525794A (ja) | 2021-07-15 | 2022-07-15 | 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240350567A1 (https=) |
| EP (1) | EP4370142A1 (https=) |
| JP (1) | JP2024525794A (https=) |
| KR (1) | KR20240038015A (https=) |
| CN (1) | CN119365205A (https=) |
| AU (1) | AU2022312760A1 (https=) |
| CA (1) | CA3222905A1 (https=) |
| IL (1) | IL309883A (https=) |
| IT (1) | IT202100018740A1 (https=) |
| MX (1) | MX2024000520A (https=) |
| WO (1) | WO2023286027A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118813489A (zh) * | 2024-08-29 | 2024-10-22 | 北京科拓恒通生物技术股份有限公司 | 一种用于缓解便秘和腹泻的益生菌后生元和制备方法及其用途 |
| CN120361059A (zh) * | 2025-06-30 | 2025-07-25 | 天津创源生物技术有限公司 | 一种副干酪乳酪杆菌iob413后生元在胃食管反流上的应用 |
| CN121533530A (zh) * | 2026-01-19 | 2026-02-17 | 内蒙古农业大学 | 一种副干酪乳酪杆菌-复合益生元复配制剂、制备方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784798B2 (en) * | 2009-05-11 | 2014-07-22 | Nestec S.A. | Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders |
| IT201900000801A1 (it) * | 2019-01-18 | 2020-07-18 | Proge Farm Srl | Composizione comprendente batteri probiotici non vitali e suo uso in terapia |
| IT201900016865A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e loro uso come antinfiammatori |
| IT201900016811A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
| IT201900020422A1 (it) * | 2019-11-05 | 2021-05-05 | Sofar Spa | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine |
| IT202000012448A1 (it) * | 2020-05-26 | 2021-11-26 | Sofar Spa | Composizioni comprendenti un derivato della cannabis sativa e ceppi di batteri e loro uso terapeutico |
| IT202100008300A1 (it) * | 2021-04-01 | 2022-10-01 | Bll Invest S R L | Ceppi di batteri inattivati, quali batteri vitali ma non coltivabili, loro composizioni e loro uso |
-
2021
- 2021-07-15 IT IT102021000018740A patent/IT202100018740A1/it unknown
-
2022
- 2022-07-15 EP EP22751158.1A patent/EP4370142A1/en active Pending
- 2022-07-15 WO PCT/IB2022/056538 patent/WO2023286027A1/en not_active Ceased
- 2022-07-15 IL IL309883A patent/IL309883A/en unknown
- 2022-07-15 US US18/579,158 patent/US20240350567A1/en active Pending
- 2022-07-15 CN CN202280049761.9A patent/CN119365205A/zh active Pending
- 2022-07-15 KR KR1020247005329A patent/KR20240038015A/ko active Pending
- 2022-07-15 MX MX2024000520A patent/MX2024000520A/es unknown
- 2022-07-15 AU AU2022312760A patent/AU2022312760A1/en active Pending
- 2022-07-15 JP JP2024502018A patent/JP2024525794A/ja active Pending
- 2022-07-15 CA CA3222905A patent/CA3222905A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bustamante et al. | Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract | |
| Savino et al. | Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial | |
| KR20230170647A (ko) | 비피도박테리움 락티스 및 그 사용 | |
| RS58549B1 (sr) | Kompozicije koje sadrže bakterijski soj blautia hydrogenotrophica za upotrebu u lečenju ili prevenciji dijareje ili konstipacije | |
| JP2024525794A (ja) | 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用 | |
| EP3986163A2 (en) | Microbial compositions and methods for producing upgraded probiotic assemblages | |
| JP2025165999A (ja) | 菌株、組成物および使用方法 | |
| RS62079B1 (sr) | Upotreba probiotika u lečenju i/ili prevenciji atopijskog dermatitisa | |
| EP4108260A1 (en) | Composition for alleviating pulmonary hypertension, method for predicting prognosis of pulmonary hypertension, method for assisting in determining severity of pulmonary hypertension, and method for assisting in diagnosing pulmonary hypertension | |
| Yang et al. | Precise strategies for selecting probiotic bacteria in treatment of intestinal bacterial dysfunctional diseases | |
| KR20230131850A (ko) | 아동의 성장 및 사회 기능을 향상시키기 위한 프로바이오틱스조성물 및 이의 사용 방법 | |
| Zhang et al. | Lactiplantibacillus plantarum ST-III-fermented milk improves autistic-like behaviors in valproic acid-induced autism spectrum disorder mice by altering gut microbiota | |
| CN114728028A (zh) | 包括具有增强的持久性的新微生物的组合物、新微生物和益生元的协同组合 | |
| KR20240093392A (ko) | 질병 치료를 위한 조성물 및 방법 | |
| EP4251183A1 (en) | Methods of preventing, delaying or ameliorating atopic diseases | |
| JP2022504185A (ja) | 細菌株を含む組成物 | |
| US11850270B2 (en) | Probiotics and methods of use | |
| JPWO2023286027A5 (https=) | ||
| EA053058B1 (ru) | Применение бактериальных штаммов lactobacillus paracasei для лечения новорожденных | |
| Shan et al. | 3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition | |
| KR20220118423A (ko) | 박테리아 균주를 포함하는 조성물 | |
| DK202430232A1 (en) | Nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides | |
| WO2025219497A1 (en) | Combination comprising bifidobacterium bifidum ha-132 and human milk oligosaccharides | |
| WO2025219495A1 (en) | A nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides | |
| WO2025219496A1 (en) | Nutritional composition comprising bifidobacterium longum ssp. infantis r0033 and human milk oligosaccharides |